
ABX-002 is a novel CNS-penetrant TR-B агонист prodrug with significant potential for treating demyelinating disorders (e.g., multiple sclerosis), neuroinflammatory diseases (e.g., ALS, Alzheimer's), and neurodegenerative diseases (e.g., Parkinson's, Huntington's). Its ability to promote remyelination, reduce inflammation, and protect neurons makes it a promising therapeutic candidate for a range of CNS disorders.
ABX-002 is a novel CNS-penetrant TR-B agonist prodrug with significant potential for treating demyelinating disorders (e.g., multiple sclerosis), neuroinflammatory diseases (e.g., ALS, Alzheimer's), and neurodegenerative diseases (e.g., Parkinson's, Huntington's). Its ability to promote remyelination, reduce inflammation, and protect neurons makes it a promising therapeutic candidate for a range of CNS disorders.
Вращайте мышью · Колесо — масштаб
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.